Zeming Mo

564 total citations
11 papers, 369 citations indexed

About

Zeming Mo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Zeming Mo has authored 11 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Zeming Mo's work include CAR-T cell therapy research (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Nanowire Synthesis and Applications (2 papers). Zeming Mo is often cited by papers focused on CAR-T cell therapy research (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Nanowire Synthesis and Applications (2 papers). Zeming Mo collaborates with scholars based in China and Canada. Zeming Mo's co-authors include Yuquan Wei, Binglan Zhang, Wei Du, Yan Wang, Lei Liu, Yongsheng Wang, Diyuan Qin, Yi Li, Wei Wei and Wei Wang and has published in prestigious journals such as Journal of Biological Chemistry, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Immunology.

In The Last Decade

Zeming Mo

10 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeming Mo China 7 164 143 113 85 78 11 369
Roger Tell Sweden 10 166 1.0× 95 0.7× 60 0.5× 49 0.6× 73 0.9× 22 390
S. Guihard France 10 116 0.7× 125 0.9× 100 0.9× 70 0.8× 66 0.8× 47 342
Jahan Aghalar United States 5 269 1.6× 82 0.6× 133 1.2× 66 0.8× 47 0.6× 9 355
D. Spielsinger United States 5 268 1.6× 91 0.6× 125 1.1× 76 0.9× 23 0.3× 11 352
Cheng Lin China 12 250 1.5× 136 1.0× 137 1.2× 106 1.2× 131 1.7× 38 467
Katrin Håkansson Denmark 11 136 0.8× 195 1.4× 151 1.3× 95 1.1× 34 0.4× 23 403
Vidhya Karivedu United States 10 129 0.8× 86 0.6× 129 1.1× 71 0.8× 71 0.9× 35 322
Won Kyung Cho South Korea 12 207 1.3× 25 0.2× 165 1.5× 135 1.6× 72 0.9× 56 462
Felix Ho United States 8 198 1.2× 69 0.5× 81 0.7× 121 1.4× 34 0.4× 16 298

Countries citing papers authored by Zeming Mo

Since Specialization
Citations

This map shows the geographic impact of Zeming Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeming Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeming Mo more than expected).

Fields of papers citing papers by Zeming Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeming Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeming Mo. The network helps show where Zeming Mo may publish in the future.

Co-authorship network of co-authors of Zeming Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Zeming Mo. A scholar is included among the top collaborators of Zeming Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeming Mo. Zeming Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Bao, Yiwen, Zeming Mo, Jinhua Long, et al.. (2024). Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023. Frontiers in Immunology. 15. 1475062–1475062. 1 indexed citations
3.
Zheng, Chunfu, Jie Liu, Zijing Liu, et al.. (2024). Efficacies of anlotinib monotherapy versus gemcitabine-based chemotherapy for patients with advanced soft tissue sarcoma after the failure of anthracycline-based chemotherapy. Journal of Cancer Research and Clinical Oncology. 150(2). 58–58. 1 indexed citations
4.
Mo, Zeming, et al.. (2024). Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS). Frontiers in Pharmacology. 15. 1288362–1288362. 6 indexed citations
5.
Mo, Zeming, et al.. (2023). Association of NRAS mutations and tertiary lymphoid structure formation with clinical outcomes of adjuvant PD-1 inhibitors for acral melanoma. International Immunopharmacology. 124(Pt B). 110973–110973. 5 indexed citations
7.
Li, Xiaoyu, Youling Gong, Dan Li, et al.. (2020). Low-Dose Radiation Therapy Promotes Radiation Pneumonitis by Activating NLRP3 Inflammasome. International Journal of Radiation Oncology*Biology*Physics. 107(4). 804–814. 42 indexed citations
8.
Mo, Zeming, Peixin Du, Guoping Wang, & Yongsheng Wang. (2017). The Multi-Purpose Tool of Tumor Immunotherapy: Gene-Engineered T Cells. Journal of Cancer. 8(9). 1690–1703. 15 indexed citations
10.
Zhang, Binglan, Diyuan Qin, Zeming Mo, et al.. (2016). Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors. Science China Life Sciences. 59(4). 340–348. 86 indexed citations
11.
Zhang, Binglan, Zeming Mo, Wei Du, et al.. (2015). Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis. Oral Oncology. 51(11). 1041–1046. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026